Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Stroke

  Free Subscription


Articles published in Lancet Neurol

Retrieve available abstracts of 52 articles:
HTML format
Text format



Single Articles


    May 2017
  1. BERGE E, Salman RA, van der Worp HB, Stapf C, et al
    Increasing value and reducing waste in stroke research.
    Lancet Neurol. 2017;16:399-408.
    PubMed     Text format     Abstract available


    March 2017
  2. HESS DC, Wechsler LR, Clark WM, Savitz SI, et al
    Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.
    Lancet Neurol. 2017 Mar 17. pii: S1474-4422(17)30046.
    PubMed     Text format     Abstract available


  3. DAVALOS A, Cobo E, Molina CA, Chamorro A, et al
    Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial.
    Lancet Neurol. 2017 Mar 16. pii: S1474-4422(17)30047.
    PubMed     Text format     Abstract available


  4. FASSBENDER K, Grotta JC, Walter S, Grunwald IQ, et al
    Mobile stroke units for prehospital thrombolysis, triage, and beyond: benefits and challenges.
    Lancet Neurol. 2017;16:227-237.
    PubMed     Text format     Abstract available


  5. ELKINS J, Veltkamp R, Montaner J, Johnston SC, et al
    Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial.
    Lancet Neurol. 2017;16:217-226.
    PubMed     Text format     Abstract available


  6. TATLISUMAK T
    Can natalizumab be beneficial in acute ischaemic stroke?
    Lancet Neurol. 2017;16:176-177.
    PubMed     Text format    


    February 2017
  7. AMARENCO P, Albers GW, Denison H, Easton JD, et al
    Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial.
    Lancet Neurol. 2017 Feb 23. pii: S1474-4422(17)30038.
    PubMed     Text format     Abstract available


  8. WACHTER R, Groschel K, Gelbrich G, Hamann GF, et al
    Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial.
    Lancet Neurol. 2017 Feb 7. pii: S1474-4422(17)30002.
    PubMed     Text format     Abstract available


  9. BRACARD S, Ducrocq X, Guillemin F, Moulin T, et al
    Mechanical thrombectomy after intravenous thrombolysis for acute ischaemic stroke - Authors' reply.
    Lancet Neurol. 2017;16:104.
    PubMed     Text format    


  10. BADHIWALA JH, Nassiri F, Kulkarni AV, Spears J, et al
    Mechanical thrombectomy after intravenous thrombolysis for acute ischaemic stroke.
    Lancet Neurol. 2017;16:103.
    PubMed     Text format    


  11. MORELLI N, Rota E, Michieletti E, Guidetti D, et al
    Mechanical thrombectomy after intravenous thrombolysis for acute ischaemic stroke.
    Lancet Neurol. 2017;16:103-104.
    PubMed     Text format    


    November 2016
  12. KELLY PJ, Albers GW, Chatzikonstantinou A, De Marchis GM, et al
    Validation and comparison of imaging-based scores for prediction of early stroke risk after transient ischaemic attack: a pooled analysis of individual-patient data from cohort studies.
    Lancet Neurol. 2016;15:1238-1247.
    PubMed     Text format     Abstract available


  13. HANLEY DF, Thompson RE, Muschelli J, Rosenblum M, et al
    Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial.
    Lancet Neurol. 2016;15:1228-1237.
    PubMed     Text format     Abstract available


    October 2016
  14. TANG M, Ryman DC, McDade E, Jasielec MS, et al
    Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS).
    Lancet Neurol. 2016 Oct 21. pii: S1474-4422(16)30229.
    PubMed     Text format     Abstract available


    April 2016
  15. KIRBY T
    Philip B Gorelick: changing neurological practice in the USA.
    Lancet Neurol. 2016;15:361.
    PubMed     Text format    


  16. BURTON A
    South Africa: stroke units out of the blue.
    Lancet Neurol. 2016;15:359-60.
    PubMed     Text format    


    January 2016
  17. MUIR KW
    Stroke in 2015: the year of endovascular treatment.
    Lancet Neurol. 2016;15:2-3.
    PubMed     Text format    


    December 2015
  18. MARSHALL IJ, Wang Y, Crichton S, McKevitt C, et al
    The effects of socioeconomic status on stroke risk and outcomes.
    Lancet Neurol. 2015;14:1206-1218.
    PubMed     Text format     Abstract available


    November 2015
  19. PITKANEN A, Roivainen R, Lukasiuk K
    Development of epilepsy after ischaemic stroke.
    Lancet Neurol. 2015 Nov 13. pii: S1474-4422(15)00248.
    PubMed     Text format     Abstract available


    October 2015
  20. KWAKKEL G, Meskers CG
    Botulinum toxin A for upper limb spasticity.
    Lancet Neurol. 2015;14:969-71.
    PubMed     Text format    


    September 2015
  21. BURTON A
    Peter Rothwell: aspirin(g) physician with a little stroke of genius.
    Lancet Neurol. 2015;14:878.
    PubMed     Text format    


  22. COMPTER A, van der Worp HB, Algra A, Kappelle LJ, et al
    Risks of stenting in patients with extracranial and intracranial vertebral artery stenosis.
    Lancet Neurol. 2015;14:875.
    PubMed     Text format    


  23. WU CY, Chang KC
    Constraint-induced movement therapy translated into practice.
    Lancet Neurol. 2015;14:869-71.
    PubMed     Text format    


    August 2015
  24. GRACIES JM, Brashear A, Jech R, McAllister P, et al
    Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
    Lancet Neurol. 2015 Aug 26. pii: S1474-4422(15)00216.
    PubMed     Text format     Abstract available


    July 2015
  25. BARZEL A, Ketels G, Stark A, Tetzlaff B, et al
    Home-based constraint-induced movement therapy for patients with upper limb dysfunction after stroke (HOMECIMT): a cluster-randomised, controlled trial.
    Lancet Neurol. 2015 Jul 28. pii: S1474-4422(15)00147.
    PubMed     Text format     Abstract available


  26. LI L, Yiin GS, Geraghty OC, Schulz UG, et al
    Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study.
    Lancet Neurol. 2015 Jul 27. pii: S1474-4422(15)00132.
    PubMed     Text format     Abstract available


  27. FERRO JM
    Ischaemic stroke of undetermined cause.
    Lancet Neurol. 2015 Jul 27. pii: S1474-4422(15)00149.
    PubMed     Text format    


  28. FISHER M, Saver JL
    Future directions of acute ischaemic stroke therapy.
    Lancet Neurol. 2015;14:758-67.
    PubMed     Text format     Abstract available


  29. SANDERCOCK PA
    A call to revolutionise acute stroke care and research.
    Lancet Neurol. 2015;14:674-5.
    PubMed     Text format    


    June 2015
  30. CAMPBELL BC, Donnan GA, Lees KR, Hacke W, et al
    Endovascular stent thrombectomy: the new standard of care for large vessel ischaemic stroke.
    Lancet Neurol. 2015 Jun 25. pii: S1474-4422(15)00140.
    PubMed     Text format     Abstract available


  31. TURAN TN, Chimowitz MI
    Yet again no benefit of stenting over medical therapy.
    Lancet Neurol. 2015;14:565-6.
    PubMed     Text format    


  32. COMPTER A, van der Worp HB, Schonewille WJ, Vos JA, et al
    Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial.
    Lancet Neurol. 2015;14:606-14.
    PubMed     Text format     Abstract available


    April 2015
  33. ALBERS GW, von Kummer R, Truelsen T, Jensen JK, et al
    Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial.
    Lancet Neurol. 2015 Apr 30. pii: S1474-4422(15)00047.
    PubMed     Text format     Abstract available


  34. HILL MD, Menon BK
    Desmoteplase for late treatment of stroke: still in the dark.
    Lancet Neurol. 2015 Apr 30. pii: S1474-4422(15)00061.
    PubMed     Text format    


  35. KASNER SE
    CADISS: a feasibility trial that answered its question.
    Lancet Neurol. 2015;14:342-3.
    PubMed     Text format    


  36. MARKUS HS, Hayter E, Levi C, Feldman A, et al
    Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial.
    Lancet Neurol. 2015;14:361-7.
    PubMed     Text format     Abstract available


    March 2015

  37. Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial.
    Lancet Neurol. 2015 Mar 26. pii: S1474-4422(15)00012.
    PubMed     Text format     Abstract available


  38. LARRUE V
    Brain CT signs and the effect of alteplase after stroke.
    Lancet Neurol. 2015 Mar 26. pii: S1474-4422(15)00013.
    PubMed     Text format    


  39. THE LANCET NEUROLOGY
    The stroke care revolution.
    Lancet Neurol. 2015 Mar 5. pii: S1474-4422(15)70023.
    PubMed     Text format    


  40. SPOSATO LA, Cipriano LE, Saposnik G, Vargas ER, et al
    Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis.
    Lancet Neurol. 2015 Mar 3. pii: S1474-4422(15)70027.
    PubMed     Text format     Abstract available


  41. ABDUL-RAHIM AH, Lees KR
    Screening for atrial fibrillation after stroke or TIA.
    Lancet Neurol. 2015 Mar 3. pii: S1474-4422(15)70039.
    PubMed     Text format    


    February 2015
  42. SCHWAMM LH
    Breaking up is hard to do: tenecteplase in acute stroke.
    Lancet Neurol. 2015 Feb 25. pii: S1474-4422(15)70036.
    PubMed     Text format    


  43. HUANG X, Cheripelli BK, Lloyd SM, Kalladka D, et al
    Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study.
    Lancet Neurol. 2015 Feb 25. pii: S1474-4422(15)70017.
    PubMed     Text format     Abstract available


  44. KWAKKEL G, Veerbeek JM, van Wegen EE, Wolf SL, et al
    Constraint-induced movement therapy after stroke.
    Lancet Neurol. 2015;14:224-234.
    PubMed     Text format     Abstract available


    January 2015
  45. KIRTON A, deVeber G
    Paediatric stroke: pressing issues and promising directions.
    Lancet Neurol. 2015;14:92-102.
    PubMed     Text format     Abstract available


  46. GORELICK PB, Farooq MU
    Stroke: an emphasis on guidelines.
    Lancet Neurol. 2015;14:2-3.
    PubMed     Text format    


    December 2014

  47. Effect of intermittent pneumatic compression on disability, living circumstances, quality of life, and hospital costs after stroke: secondary analyses from CLOTS 3, a randomised trial.
    Lancet Neurol. 2014;13:1186-92.
    PubMed     Text format     Abstract available


  48. PEARCE LA, McClure LA, Anderson DC, Jacova C, et al
    Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial.
    Lancet Neurol. 2014;13:1177-85.
    PubMed     Text format     Abstract available


  49. KOHLER S, Hackett ML, O'Brien JT, Mead GE, et al
    Neuropsychiatric outcomes after stroke - Authors' reply.
    Lancet Neurol. 2014;13:1168-9.
    PubMed     Text format    


  50. KALLIO ME
    Neuropsychiatric outcomes after stroke.
    Lancet Neurol. 2014;13:1168.
    PubMed     Text format    


  51. HANKEY GJ
    Intermittent pneumatic compression after stroke.
    Lancet Neurol. 2014;13:1163-5.
    PubMed     Text format    


  52. HILLIS AE
    Blood pressure control after stroke: too little, too late, or too soon to tell?
    Lancet Neurol. 2014;13:1162-3.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: